These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33609926)

  • 1. Prevalence of neuromyelitis optica spectrum disorder in Belo Horizonte, Southeast Brazil.
    Lana-Peixoto MA; Talim NC; Pedrosa D; Macedo JM; Santiago-Amaral J
    Mult Scler Relat Disord; 2021 May; 50():102807. PubMed ID: 33609926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated prevalence of AQP4 positive neuromyelitis optica spectrum disorder and MOG antibody associated disease in São Paulo, Brazil.
    Silva GD; Apóstolos-Pereira SL; Callegaro D
    Mult Scler Relat Disord; 2023 Feb; 70():104488. PubMed ID: 36610359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological findings of neuromyelitis optica spectrum disorders in a Venezuelan study.
    Ibis SC; Omaira M; Arnoldo S; Elizabeth A; Sandra M; Carlota CM; Elizabeth C; Laura V; Rosalba L; Oscar V; Luisa DM; Nahir A; Hernandez F
    Mult Scler Relat Disord; 2021 Jan; 47():102652. PubMed ID: 33279797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric-onset multiple sclerosis in Brazilian patients: Clinical features, treatment response and comparison to pediatric neuromyelitis optica spectrum disorders.
    Fragomeni MO; Bichuetti DB; Oliveira EML
    Mult Scler Relat Disord; 2018 Oct; 25():138-142. PubMed ID: 30075406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.
    Stastna D; Menkyova I; Drahota J; Mazouchova A; Adamkova J; Ampapa R; Grunermelova M; Peterka M; Recmanova E; Rockova P; Rous M; Stetkarova I; Valis M; Vachova M; Woznicova I; Horakova D
    Mult Scler Relat Disord; 2021 Sep; 54():103104. PubMed ID: 34216998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
    Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
    Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population.
    Silveira F; Pappolla A; Sánchez F; Marques VD; de Castillo IS; Tkachuk V; Caride A; Castillo MC; Cristiano E; Cruz CA; Diégues Serva GB; Dos Santos AC; Moreira CL; López PA; Patrucco L; Molina O; Pettinicchi JP; Carnero Contentti E; Rojas JI
    Mult Scler Relat Disord; 2020 Jul; 42():102049. PubMed ID: 32251869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nationwide epidemiological study on the prevalence of multiple sclerosis and neuromyelitis optica spectrum disorder with important multi-ethnic differences in Malaysia.
    Viswanathan S; Wah LM
    Mult Scler; 2019 Oct; 25(11):1452-1461. PubMed ID: 30113245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis.
    Bagherieh S; Afshari-Safavi A; Vaheb S; Kiani M; Ghaffary EM; Barzegar M; Shaygannejad V; Zabeti A; Mirmosayyeb O
    Neurol Sci; 2023 Jun; 44(6):1905-1915. PubMed ID: 36745300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone health in neuromyelitis optica: Bone mineral density and fractures.
    Kwon YN; Im SY; Park YS; Ahn SH; Seo J; Kim SB; Yoon SS; Waters P; Choi HJ; Kong SH; Sung JJ; Kim SM; Park KS
    Mult Scler Relat Disord; 2020 Jul; 42():102080. PubMed ID: 32497999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.
    Fabis-Pedrini MJ; Bundell C; Wee CK; Lucas M; McLean-Tooke A; Mastaglia FL; Carroll WM; Kermode AG
    J Neuroimmunol; 2018 Nov; 324():76-80. PubMed ID: 30248527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis and neuromyelitis optica spectrum disorders in Malaysia: A comparison in different ethnic groups.
    Viswanathan S; Rose N; Arip M; Chai CH; Law WC; Sim R; Ong MC
    Mult Scler Relat Disord; 2018 Oct; 25():300-308. PubMed ID: 30172173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of prevalence rates of restless legs syndrome, self-assessed risks of obstructive sleep apnea, and daytime sleepiness among patients with multiple sclerosis (MS), clinically isolated syndrome (CIS) and Neuromyelitis Optica Spectrum Disorder (NMOSD).
    Shaygannejad V; Sadeghi Bahmani D; Soleimani P; Mirmosayyeb O; Barzegar M; Amra B; Brand S
    Sleep Med; 2020 Jun; 70():97-105. PubMed ID: 32276200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sociodemographic and clinical characteristics of people with multiple sclerosis and neuro-myelitis optica spectrum disorder in a central northern region of Chile: A prevalence study.
    Henríquez K; Molt F; Gajardo J; Cortés B; Ramirez-Santana M
    Mult Scler Relat Disord; 2022 May; 61():103750. PubMed ID: 35339742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM).
    Rojas JI; Alonso Serena M; Garcea O; Patrucco L; Carrá A; Correale J; Vrech C; Pappolla A; Miguez J; Doldan ML; Silveira F; Alonso R; Cohen L; Pita C; Silva BA; Fiol M; Gaitán MI; Marrodan M; Negrotto L; Ysrraelit MC; Deri N; Luetic G; Caride A; Carnero Contentti E; Lopez PA; Pettinicchi JP; Curbelo C; Martinez AD; Steinberg JD; Balbuena ME; Tkachuk V; Burgos M; Knorre E; Leguizamon F; Piedrabuena R; Liwacki SDV; Barboza AG; Nofal P; Volman G; Alvez Pinheiro A; Hryb J; Tavolini D; Blaya PA; Silva E; Blanche J; Tizio S; Caceres F; Saladino ML; Zanga G; Fracaro ME; Sgrilli G; Pagani Cassara F; Vazquez G; Sinay V; Menichini ML; Lazaro L; Cabrera LM; Bestoso S; Divi P; Jacobo M; Kohler E; Kohler M; Giunta D; Mainella C; Manzi R; Parada Marcilla M; Viglione JP; Martos I; Reich E; Jose G; Cristiano E; Fernández Liguori N;
    Neurol Sci; 2020 Jun; 41(6):1513-1519. PubMed ID: 31960250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of neuromyelitis optica spectrum disorder in the Central Denmark Region.
    Dale GH; Svendsen KB; Gjelstrup MC; Christensen T; Houen G; Nielsen E; Bek T; Petersen T
    Acta Neurol Scand; 2018 Jun; 137(6):582-588. PubMed ID: 29359475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial forms of multiple sclerosis and neuromyelitis optica at an MS center in Rio de Janeiro State, Brazil.
    Papais-Alvarenga RM; Pereira FF; Bernardes MS; Papais-Alvarenga M; Batista E; Paiva CA; Santos CM; Vasconcelos CC
    J Neurol Sci; 2015 Sep; 356(1-2):196-201. PubMed ID: 26115914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis.
    Messina S; Mariano R; Geraldes R; Kim SH; Satukijcha C; Vecchio D; Chua YY; Taylor J; George N; Cavey A; Diaz AR; Reeve S; Everett R; De Luca G; Leite MI; Kim HJ; Palace J
    Mult Scler Relat Disord; 2021 Apr; 49():102773. PubMed ID: 33540279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kim SH; Kwak K; Jeong IH; Hyun JW; Jo HJ; Joung A; Yu ES; Kim JH; Lee SH; Yun S; Joo J; Lee DK; Lee JM; Kim HJ
    Mult Scler; 2016 Dec; 22(14):1850-1858. PubMed ID: 26920380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Nakamura Y; Liu Z; Fukumoto S; Shinoda K; Sakoda A; Matsushita T; Hayashida S; Isobe N; Watanabe M; Hiwatashi A; Yamasaki R; Kira JI
    Eur J Neurol; 2020 Jan; 27(1):92-99. PubMed ID: 31304648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.